DATATRAK Adds New CDISC Standard - Terminology

                DATATRAK Adds New CDISC Standard - Terminology

PR Newswire

CLEVELAND, June 26, 2013

CLEVELAND, June 26, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX:
DTRK), a leader in developing cloud-based, unified eClinical® technologies and
delivering related services for the clinical trials industry, today announced
it received the CDISC Terminology Registered Solutions Provider status.
DATATRAK is a leader in driving standards compliance with a total of six
registrations– CDASH, LAB, ODM, SDTM, Define.XML and Terminology.

(Logo:http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)

"As a Charter Member of CDISC, we have been championing standards for over
twelve years," stated Dr. Bill Gluck, VP of Clinical and Consulting Services.
"Completing DATATRAK's sixth Registered Solutions Provider status demonstrates
our steadfast commitment to implementing industry standards. We use our CDISC
standards expertise to guide our clients in the harmonization of their
clinical data which ultimately streamlines the data analysis phase and
accelerates of the drug development process."

Join DATATRAK Thought Leaders:

  oLinkedIn
  oSlideShare
  oThe DATATRAK Blog
  oFacebook

Tweet: DATATRAK now CDISC Terminology RSP http://bit.ly/17Bm8Y2 

About DATATRAK
DATATRAK International is a worldwide technology and services company
delivering unified eClinical® solutions and related services for the clinical
trials industry. DATATRAK built its multi-component, comprehensive solution on
a single, unified platform and expanded this concept to include services
delivery via DATATRAK's Clinical and Consulting Services group. The Company
delivers a complete portfolio of software products designed to accelerate the
reporting of clinical research data from sites to sponsors and ultimately
regulatory authorities, faster and more efficiently than loosely integrated
technologies. The DATATRAK ONE™ software solution, deployed worldwide through
an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and
device studies in multiple languages throughout the world. DATATRAK has
offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North
Carolina. For more information, visithttp://www.datatrak.com. 

Except for the historical information contained in this press release, the
statements made in this release are forward-looking statements. These
forward-looking statements are made based on management's expectations,
assumptions, estimates and current beliefs concerning the operations, future
results and prospects of the Company and are subject to uncertainties and
factors which are difficult to predict and, in many instances, are beyond the
control of the Company, and which could cause actual results to differ
materially from those contemplated in these forward-looking statements. For a
list of certain factors that may cause actual results to differ materially
from those contemplated in these forward looking statements, please see the
Company's report filed with the OTCQX Market on May 15, 2013 announcing its
results for the first quarter of 2013. The Company undertakes no obligation to
update publicly or revise any forward-looking statement whether as a result of
new information, future events or otherwise.

SOURCE DATATRAK International, Inc.

Website: http://www.datatrak.net
Contact: Lisa Pahl, Director Marketing, DATATRAK International, Inc.,
+1-979-393-9025
 
Press spacebar to pause and continue. Press esc to stop.